Musiime V - Search Results

1

Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study.

Nalwanga D, Musiime V, Bangirana P, Nishiguchi EP, Kiggwe A, Ssesanga T, Ssenkusu JM, Musoke P, Cusick SE. Nalwanga D, et al. Among authors: musiime v. BMC Pediatr. 2021 Apr 26;21(1):198. doi: 10.1186/s12887-021-02676-2. BMC Pediatr. 2021. PMID: 33902506 Free PMC article.

2

Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine.

Musiime V, Ssali F, Kayiwa J, Namala W, Kizito H, Kityo C, Mugyenyi P. Musiime V, et al. AIDS Res Hum Retroviruses. 2009 Oct;25(10):989-96. doi: 10.1089/aid.2009.0054. AIDS Res Hum Retroviruses. 2009. PMID: 19778270

3

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.

Musiime V, Kendall L, Bakeera-Kitaka S, Snowden WB, Odongo F, Thomason M, Musoke P, Adkison K, Burger D, Mugyenyi P, Kekitiinwa A, Gibb DM, Walker AS; ARROW Trial team. Musiime V, et al. Antivir Ther. 2010;15(8):1115-24. doi: 10.3851/IMP1695. Antivir Ther. 2010. PMID: 21149918 Clinical Trial.

4

Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy.

Nahirya-Ntege P, Musiime V, Naidoo B, Bakeera-Kitaka S, Nathoo K, Munderi P, Mugyenyi P, Kekitiinwa A, Bwakura-Dangarembizi MF, Crawley J; ARROW Trial Team. Nahirya-Ntege P, et al. Among authors: musiime v. Pediatr Infect Dis J. 2011 Jun;30(6):535-7. doi: 10.1097/INF.0b013e3182076864. Pediatr Infect Dis J. 2011. PMID: 21164384 Clinical Trial.

5

Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda.

Fillekes Q, Natukunda E, Balungi J, Kendall L, Bwakura-Dangarembizi M, Keishanyu R, Ferrier A, Lutakome J, Gibb DM, Burger DM, Walker AS; ARROW Trial Team. Fillekes Q, et al. J Acquir Immune Defic Syndr. 2011 Dec 1;58(4):392-8. doi: 10.1097/QAI.0b013e318235e560. J Acquir Immune Defic Syndr. 2011. PMID: 21926634 Clinical Trial.

6

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.

Kasirye P, Kendall L, Adkison KK, Tumusiime C, Ssenyonga M, Bakeera-Kitaka S, Nahirya-Ntege P, Mhute T, Kekitiinwa A, Snowden W, Burger DM, Gibb DM, Walker AS; ARROW Trial Team. Kasirye P, et al. Clin Pharmacol Ther. 2012 Feb;91(2):272-80. doi: 10.1038/clpt.2011.225. Epub 2011 Dec 21. Clin Pharmacol Ther. 2012. PMID: 22190066

7

Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda.

Musiime V, Kayiwa J, Kiconco M, Tamale W, Alima H, Mugerwa H, Abwola M, Apilli E, Ahimbisibwe F, Kizito H, Abongomera G, Namusoke A, Makabayi A, Kiweewa F, Ssali F, Kityo C, Colebunders R, Mugyenyi P. Musiime V, et al. AIDS Res Hum Retroviruses. 2012 Dec;28(12):1647-57. doi: 10.1089/AID.2011.0313. Epub 2012 Jun 1. AIDS Res Hum Retroviruses. 2012. PMID: 22545751

8

Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa.

Nahirya-Ntege P, Cook A, Vhembo T, Opilo W, Namuddu R, Katuramu R, Tezikyabbiri J, Naidoo-James B, Gibb D; ARROW Trial Team. Nahirya-Ntege P, et al. PLoS One. 2012;7(5):e36186. doi: 10.1371/journal.pone.0036186. Epub 2012 May 2. PLoS One. 2012. PMID: 22567139 Free PMC article.

9

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.

Walker AS, Prendergast AJ, Mugyenyi P, Munderi P, Hakim J, Kekitiinwa A, Katabira E, Gilks CF, Kityo C, Nahirya-Ntege P, Nathoo K, Gibb DM; DART and ARROW trial teams. Walker AS, et al. Clin Infect Dis. 2012 Dec;55(12):1707-18. doi: 10.1093/cid/cis797. Epub 2012 Sep 12. Clin Infect Dis. 2012. PMID: 22972859 Free PMC article.

10

Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children.

Musiime V, Kaudha E, Kayiwa J, Mirembe G, Odera M, Kizito H, Nankya I, Ssali F, Kityo C, Colebunders R, Mugyenyi P. Musiime V, et al. AIDS Res Hum Retroviruses. 2013 Mar;29(3):449-55. doi: 10.1089/aid.2012.0283. Epub 2013 Jan 11. AIDS Res Hum Retroviruses. 2013. PMID: 23308370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page